"複十字病院は、東京都肺がん・大腸がん・乳がん診療連携協力病院です。 昭和14年に設立された財団法人結核予防会を母体とし昭和22年に結核研究所臨床部として発足しました。その後、結核研究所付属療養所から結核研究所付属病院と名称を変更するとともに、機能の充実を図り、平成元年に複十字病院となりました。"

During the past decade, Fukujuji Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fukujuji Hospital" #1 collaborator was "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fukujuji Hospital" are "Non-small-Cell Lung Cancer" (1 trials) and "Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)" (1 trials). Many other conditions were trialed in "Fukujuji Hospital" in a lesser frequency.

Most popular intervention types in "Fukujuji Hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bedaquiline" (1 trials), "Clarithromycin" (1 trials), "Ethambutol" (1 trials), "Rifabutin" (1 trials) and "Rifampicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fukujuji Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fukujuji Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fukujuji Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fukujuji Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".